Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Manipulation.
View:
Post by alleyesonme on Feb 16, 2022 6:12pm

Manipulation.

No material change within the company. It would appear big money is trying to keep shareprice down. The only motive would be to make their takeover bid more appealing...takeover attempt by year end financials?!?....sharks are circling medipharm has too much promise and ability to trade so low without someone taking a run at a buyout....official talks of a merger or buyout may be taking place as we speak...the board participated in a PP not long ago at .58c I think this could explain why they're not buying at 17c..that would be illegal if talks are underway....why so quite?? I was thinking new strategy but things just aren't adding up...I think the next news will be preceded by a trading halt...
Comment by yureja on Feb 16, 2022 7:14pm
This post has been removed in accordance with Community Policy
Comment by Conister011 on Feb 18, 2022 8:51am
Interesting points, your probably on to something.  Clean balance sheet and a unique product and facility as well as international  footprint. Would be a nice addition to larger cos.  GLTA
Comment by Starkicker on Feb 18, 2022 1:58pm
Definitely appreciate the optimistic thoughts, but all pure speculation. A more realistic approach is this company can't generate any revenue, and competitors in markets it was hoping to dominate (Europe) have all caught up with GMP certifications (somaipharma.eu as an example) over the past two years. MediPharm has nothing exceptional going for it. Why anybody would buy this pig instead of a ...more  
Comment by alleyesonme on Feb 18, 2022 4:01pm
Global demand is estimated to grow 28% annually to 2025 by Forbes...the pie is growing substantially...this time next year the conversation will be much different and so will the sentiment.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities